Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Columbia
    • Missouri Technology Expo (MU)
    • Missouri Technology Expo 2010 (MU)
    • Abstracts (Missouri Technology Expo 2010)
    • View Item
    •   MOspace Home
    • University of Missouri-Columbia
    • Missouri Technology Expo (MU)
    • Missouri Technology Expo 2010 (MU)
    • Abstracts (Missouri Technology Expo 2010)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleSubjectIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleSubjectIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    Thomsen-Friedenreich (TF) antigen in nipple aspirate fluid: biomarker for breast cancer detection

    Quinn, Thomas P. (Thomas Patrick), 1961-
    Deutscher, Susan L.
    Sauter, Edward R.
    View/Open
    [PDF] ThomsenFriedenreichAntigen[abstract].pdf (42.40Kb)
    [PDF] ThomsenFriedenreichAntigen.pdf (67.71Kb)
    Date
    2010-10
    Format
    Presentation
    Metadata
    [+] Show full item record
    Abstract
    Early detection and diagnosis are critical to successful treatment of breast cancer. Currently available breast cancer screening tools such as mammography and breast examination miss up to 40% of early breast cancers, are least effective in detecting cancer in young women whose tumors are often more aggressive, and require that an invasive needle or surgical biopsy be performed when an area of suspicion is identified to confirm the presence of malignancy. Over a million surgical or needle breast biopsies will be performed this year to diagnose 203,000 new breast cancers. Using current techniques, women will undergo 5 diagnostic biopsies to diagnose each new cancer, and each biopsy is painful, invasive and expensive. The current invention developed by researchers at the University of Missouri analyses nipple aspirate fluid (NAF) for predictive biomarkers of breast cancer. One such biomarker is the Thomsen-Friedenreich (TF) glycoantigen, which is over-expressed on the majority of breast cancer cells. NAF can be obtained non invasively and contains a small number of cancer cells, but relatively high levels of proteins and lipids. We have developed and tested in a clinical study a simple and sensitive immuno-assay for identifying the cancer-associated TF and Tn biomarkers in NAF. Antigen detection and NAF collection are inexpensive procedures, involving commercially available reagents, insuring that the procedures could be rapidly translated to the clinic upon validation. Potential Areas of Applications: * Screening for and managing breast cancer
    URI
    http://hdl.handle.net/10355/9791
    Part of
    Abstracts (Missouri Technology Expo 2010)
    Collections
    • Presentations (Missouri Technology Expo 2010)
    • Abstracts (Missouri Technology Expo 2010)

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    Send Feedback
    hosted by University of Missouri Library Systems